Minute Insight: Are Things Going Pear-Shaped For Digital Therapeutics?
Executive Summary
Pear Therapeutics is restructuring itself to lower costs following repeated disappointing performances.
You may also be interested in...
Digital Health Roundup: Cardio Smart Watches, Pear Therapeutics Own 'Reset,' Agetech Boom
In this month’s Digital Health roundup, Medtech Insight’s Reed Miller talks about iRhythm and Withings’ smartwatches business, Barnaby Pickering reviews digital therapeutics Pear Therapeutics’ restructuring, and Marion Webb presents highlights from her new series on Agetech.
Pear Therapeutics Obtains First Medicaid Coverage For PDTs
Massachusetts’ Medicaid program will cover reSET and reSET-O prescription digital therapeutics for the treatment of substance abuse disorder and opioid use disorder.
Elypta Drops Data Showing Power Of Metabolite-Based MCED Test
Elypta’s MIRAM kit for multi-cancer early detection performed well in a large-scale study.